Centrexion Therapeutics Corp
BOSTON, MA · Founded 2013 · CIK 0001592052 · Biotech · Private
Small molecule therapeutics for non-opioid pain relief and immunology
centrexion.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $189M
- 13 Form D · Jan 2024
- 33 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $14,728,886 | |
| Private capital raised | Form D · SEC | $8,750,000 | |
| Private capital raised | Form D · SEC | $10,516,500 | |
| Private capital raised | Form D · SEC | $6,905,000 | |
| Private capital raised | Form D · SEC | $11,163,500 | |
| Private capital raised | Form D · SEC | $16,564,789 | |
| Private capital raised | Form D · SEC | $5,285,000 | |
| Private capital raised | Form D · SEC | $69,566,532 | |
| Private capital raised | Form D · SEC | $13,500,000 | |
| Private capital raised | Form D · SEC | $16,475,000 | |
| Private capital raised | Form D · SEC | $10,280,238 | |
| Private capital raised | Form D · SEC | $2,300,000 | |
| Private capital raised | Form D · SEC | $3,255,467 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1935 | ANGIOTENSIN THERAPEUTICS, INC. | — | — |
| 1936 | CELLARCUS TECHNOLOGIES, LLC | — | — |
| 1937 | DeepSpace Storage Systems Inc. | — | $1.3M |
| 1938 | Centrexion Therapeutics Corp | — | $189M |
| 1939 | Aktis Oncology | — | $175M |
| 1940 | Quotient Ltd | — | $92M |
| 1941 | Myota, Inc. | — | $16M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sol BarerDirector
- Sol Barer, Ph.D.Director
- Gregg BeloffExecutive Officer
- Isaac BlechDirector
- Kerrie BradyExecutive Officer
- James CampbellDirector · Executive Officer
- James Campbell, M.D.Director · Executive Officer
- Colin HillDirector
- Dezhi Kang, Ph.D.Director
- Jeffrey KindlerDirector · Executive Officer
- J. Lopez, M.D.Director
- J.C. Lopez, M.D.Director
- Daniel MendelsonDirector
- Sara NayeemDirector
- Arnold OronskyDirector
- Randall StevensExecutive Officer
- Joseph SwedishDirector
- Shawn TomaselloDirector
- Michael WardExecutive Officer
- Peter WirthDirector
- Stella XuDirector
- Shengda ZanDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.